Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

P&U files for European approval of urinary incontinence Rx

Jan. 9, 1997

Watson's first NDA product approved

Jan. 3, 1997

Anti-TGF-beta MAbs from Celtrix

Dec. 31, 1996

LJP licenses rights to drug for lupus

Dec. 30, 1996

Nonsteroidal 5alpha-reductase inhibitors reported by Kyowa Hakko

Dec. 24, 1996

Agents for urinary incontinence reported by Dainippon

Dec. 23, 1996

Licensees sought for PKD1 gene and mutations

Dec. 17, 1996

More terazosin clinical data reported

Dec. 17, 1996

New diuretics reported by Pharmacia & Upjohn

Dec. 17, 1996

Glaxo Wellcome evaluates new alpha1a-adrenoceptor antagonist

Dec. 13, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.